CLINICO-BIOLOGICAL FEATURES AND OUTCOMES OF ACCELERATED PHASE CHRONIC LYMPHOCYTIC LEUKEMIA (AP-CLL) IN THE ERA OF TARGETED AGENTS.: PB1891